Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 63, Issue 1, Pages (July 2015)

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Volume 46, Issue 3, Pages (March 2007)

The impact of hepatitis E in the liver transplant setting

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Volume 65, Issue 1, Pages S82-S94 (October 2016)

Inflammasomes in liver diseases

Volume 61, Issue 4, Pages (October 2014)

Volume 50, Issue 4, Pages (April 2009)

Volume 68, Issue 5, Pages (May 2018)

Volume 42, Issue 6, Pages (June 2005)

Primary prevention of variceal haemorrhage: A pharmacological approach

Volume 61, Issue 6, Pages (December 2014)

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

Volume 51, Issue 6, Pages (December 2009)

The impact of hepatitis E in the liver transplant setting

Reactive oxygen species in the normal and acutely injured liver

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

NS5A inhibitors in the treatment of hepatitis C

Thrombocytopenia associated with chronic liver disease

Volume 65, Issue 1, Pages S82-S94 (October 2016)

Immigration and viral hepatitis

Volume 55, Issue 6, Pages (December 2011)

Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis Astrid Marot, Jean Henrion, Jean-François.

Virological tools to diagnose and monitor hepatitis C virus infection

Allogeneic hematopoietic cell transplant in HCV-infected patients

Living donor liver transplantation: is the hype over?

David G. Bowen, Christopher M. Walker Journal of Hepatology

Volume 69, Issue 2, Pages (August 2018)

Volume 44, Pages S19-S24 (January 2006)

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection Anaïs Vallet-Pichard,

AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.

Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure” Rakhi Maiwall,

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

Hepatitis C core protein – The “core” of immune deception?

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Amalia Gastaldelli, Giulio Marchesini Journal of Hepatology

Volume 70, Issue 1, Pages (January 2019)

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 58, Issue 3, Pages (March 2013)

Volume 62, Issue 3, Pages (March 2015)

Genomic risk of hepatitis C-related hepatocellular carcinoma

Darius Moradpour, Arash Grakoui, Michael P. Manns

Autophagy in the liver Journal of Hepatology

Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Volume 61, Issue 1, Pages S45-S57 (November 2014)

The changing role of beta-blocker therapy in patients with cirrhosis

Volume 50, Issue 4, Pages (April 2009)

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Portal vein thrombosis, cirrhosis, and liver transplantation

Immigration and viral hepatitis

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

Volume 63, Issue 1, Pages (July 2015)

Volume 51, Issue 2, Pages (August 2009)

Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences Zobair M. Younossi, Aybike Birerdinc,

The use of hemospray in portal hypertensive bleeding; a case series

Liver transplantation in children

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

Platelets arrive at the scene of fibrosis……studies

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Reversion of disease manifestations after HCV eradication

Presentation transcript:

Managing periprocedural thrombocytopenia in cirrhosis: Aiming for a safety window Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou Journal of Hepatology Volume 61, Issue 6, Pages 1199-1201 (December 2014) DOI: 10.1016/j.jhep.2014.08.051 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Changes in primary haemostasis in patients with chronic liver disease. TPO receptor agonists not only increase platelet counts but also enhance platelet activation and function. The balance between thrombosis and bleeding is fragile in chronic liver disease patients. HCV, hepatitis C virus; TPO, thrombopoietin; vWF, von Willebrand Factor. Journal of Hepatology 2014 61, 1199-1201DOI: (10.1016/j.jhep.2014.08.051) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions